$Tesla Motors(TSLA)$MW Tesla has built 3 million vehicles, a third of those in China, Elon Musk saysBy Mike MurphyCEO congratulates Shanghai factory on its 1 millionth vehicleTesla Inc. has produced more than 3 million vehicles, and a third of them have been built in China, according to Elon Musk.On Sunday, the Tesla chief executive congratulated the company's Shanghai "gigafactory" in a tweet: "Congrats Giga Shanghai on making millionth car! Total Teslas made now over 3M."The milestone came just a few weeks after Musk said Tesla's factory in Fremont, Calif., produced its 2 millionth vehicle. Tesla also has new factories in Austin, Texas, and Berlin, which Musk in June referred to as "money furnaces."The Shanghai factory opened in 2018, but it has

$AeroClean Technologies, LLC(AERC)$AEROCLEAN TECHNOLOGIES INC FILES FOR OFFERING OF UP TO 3.0 MILLION SHARES OF COMMON STOCK OFFERED BY THE SELLING STOCKHOLDER - SEC FILING

$XPeng Inc.(XPEV)$China Evergrande Group (OTCPK:EVGRF) is set to begin accepting orders for its Hengchi 5 SUV model this week, per a new regulatory filing.Preorders for the vehicle are due to open on Wednesday, with pricing expected to be far below similar offerings from domestic competitors XPeng Inc. (XPEV) and NIO (NIO). The South China Morning Post indicated that the vehicle is expected to undercut competitors at a $23,878 list price to ensure strong initial sales for the EV unit connected to the heavily distressed real estate developer Evergrande (OTCPK:EGRNF).The announcement comes only about a week after a winding-up petition against the struggling property developer was filed in Hong Kong. Trading in the name has been suspended for months

$Tesla Motors(TSLA)$Electric-car maker is also considering site in LouisianaMusk has called lithium refining a ‘license to print money’Tesla Inc. is plotting a potential lithium refinery on the gulf coast of Texas.The electric-car maker has told the state it is considering constructing a “battery-grade lithium hydroxide refining facility,” in Nueces County, which it has pitched as “the first of its kind in North America,” according to a newly-public application for tax breaks filed with the Texas Comptroller’s Office.If built, Tesla has told the state that the facility would process “raw ore material into a usable state for battery production” and that the resulting lithium hydroxide it creates would be “packaged and shipped by truck and rail to v

$iSpecimen Inc.(ISPC)$global online biospecimen marketplace that enables life scientists to search across a federated network of healthcare providers for biospecimens needed for medical research, today announced that it added Acutis Diagnostics (“Acutis”), a clinical diagnostics laboratory, to its platform as a laboratory services provider. Through the Acutis relationship, iSpecimen will now offer sequencing services to its research community that can help researchers better understand genetic mutations and their impact on diseases such as COVID-19 and cancer.

$American Virtual Cloud Technologies, Inc.(AVCT)$American Virtual Cloud Technologies Inc. shares rose to a nearly four-month high Wednesday, extending their gains after the cloud-based, real-time communications platform announced executive changes and a review of strategic alternatives.Shares rose as high as 52 cents, a level last seen on May 6, and at 2:48 p.m. ET were up 35% at 43 cents. Volume was more than 248 million shares, compared with a 65-day average of 16.3 million.American Virtual Cloud said Thursday that Kevin Keough would be its new chief executive officer, while former CEO Darrell Mays would continue to serve as executive vice chairman of the board.The company also said it had retained Northland Capital Markets to advise its strateg

$Aurora Mobile Ltd(JG)$Aurora Mobile (NASDAQ:JG) stock jumped 8.4% premarket Wednesday after the firm's unit entered into a partnership with a global new energy vehicle manufacturer.The unit, Wuhan SendCloud Technology, will provide email services to the automaker.SendCloud is an email API platform in China.a.

$Apple(AAPL)$When it comes to Apple (NASDAQ:AAPL), there's no secret as to what is responsible for the company's staggeringly high revenue numbers.That, of course, would be the iPhone, which in Apple's (AAPL) most-recent quarter accounted for $40.7B of the company's nearly $83B in sales. Even 15 years after it was first introduced, the iPhone remains such a juggernaut that it regularly makes up more than 50% of Apple's (AAPL) sales during the Christmas and end-of-the-year holiday quarter.And then there is Apple's (AAPL) services business, which includes everything from Apple TV+ to iCloud storage plans to Apple Music monthly subscriptions. Services have become such as cash cow for Apple (AAPL) that they totaled more than $19B in Apple's (AAPL) rec

$Can Fite Biofarma(CANF)$Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis TrialCan-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial

$Apple(AAPL)$there more fuel left in Apple's growth engine? Because the company has already delivered market-beating returns for years and is near the top of the exclusive group of trillion-dollar companies, some investors are wondering if it's time to cash in. Others still see signs that Apple isn't done growing just yet.The Silicon Valley giant produced more evidence of its still-solid prospects when it released its latest quarterly update late last month. In it were clues that there are at least three reasons to think Apple isn't done growing yet and there is still time to get in on outsized returns. Let's take a look at those reasons.AAPL data by YCharts1. Despite economic headwinds, Apple is managing to do wellFears of a coming (or already pr

$Grab Holdings(GRAB)$Grab(NASDAQ:GRAB)is scheduled to announce its Q2 earnings results before the market opens on next Thursday, August 25.Latest ResultsIt reported a Q1 loss of $0.11 per diluted share, narrower than the per-share loss of $3.18 a year earlier.Revenue was $228 million, up from $216 million a year earlier. Loss narrowed to $435 million from $666 million.Its gross merchandise volume (GMV) rose 32% in Q1 to $4.8 billion from a year earlier.Stocks surged 24.11% after posting the financial results on that day.Q2 GuidanceFor Q2, Grab forecast GMV for deliveries between $2.55 billion and $2.65 billion, and for the mobility segment to be between $0.95 billion and $1 billion, betting the worst of the pandemic was over. For full-year fiscal

$AeroClean Technologies, LLC(AERC)$AeroClean Technologies Inc. shares skyrocketed for a second trading day after the company said the Food and Drug Administration granted 510(k) clearance to its Purgo air purification technology, classifying it as a Class II Medical Device.AeroClean shares closed at $2.37 Friday, and ended the day at $4.75 on Monday. Shares rose 155% to $12.10 on Tuesday in the regular session, and were recently at $11.11 after hours.The Purgo device uses germicidal UV-C LED air purification technology. The company said it is "proven to eliminate 99.99% of harmful airborne microorganisms, including bacteria, fungi and viruses, like COVID-19."AeroClean said Purgo has been "rigorously tested in a variety of laboratory test chambers

$Apple(AAPL)$Apple's AR/MR headset will the most complicated product it ever designed - Ming-Chi KuoSays Cupertino's stock and those of its AR/MR suppliers in for a positive re-rating in the 2-3 years

$Apple(AAPL)$Apple Inc. shares rallied the most since May as pre-order data showed the iPhone 14 Pro Max was the best selling model, surpassing what the older version did in a similar timeframe.Shares of the tech giant rose 3.9%, their biggest one-day gain since May 27, and the stock closed above its 200-day moving average for the first time since August. Analysts from JPMorgan to Barclays wrote that the data point to strong demand for the latest mobile phone series, which was unveiled at its product launch event last week.“Pre-order data shows that the iPhone 14 Pro Max is the best-selling model, and that it is doing better than the iPhone 13 Pro Max did at this point,” KGI Securities analyst Christine Wang wrote in a report. The pricing of the i

$Grab Holdings(GRAB)$Grab shares surged 13% in morning trading after Grab Holdings initiated with a Buy at Deutsche Bank.Deutsche Bank analyst ReenaVerma Bhasin initiated coverage of Grab Holdings with a Buy rating and $3.20 price target. Grab is Southeast Asia's leading "superapp" platform, with a dominant position in mobility and deliveries, and a developing business in digital financial services, Bhasin tells investors in a research note. The stock offers "attractive upside potential" after dropping 65% year-to-date, says the analyst. Bhasin expects strong growth in mobility and says the deliveries business is also targeted to break even over next 12 months.hs.

$Rivian Automotive, Inc.(RIVN)$Rivian is witnessing robust demand for its electric vehicles. But will the company be able to meet the strong demand, or will supply chain issues continue to impact production and drag down the stock further?Like its other electric vehicle peers, Rivian Automotive (NASDAQ: RIVN) has also been under pressure due to chip shortages and supply chain bottlenecks. These issues, along with higher input costs amid soaring inflation, have pulled down Rivian shares by 74% this year.Rivian currently manufactures R1T pickup trucks and R1S SUVs for the retail consumers, and EDVs or Electric Delivery Vans for the commercial market.Financial SnapshotLast month, Rivian posted an adjusted net loss of $1.43 per share on revenue of $95

$Apple(AAPL)$Apple’s blockbuster Far Out show has the world buzzing over what could potentially be the most successful iteration of the iPhone. Moreover, with its relatively strong results in the third quarter, it has the potential to continue expanding its top and bottom-line results.September has been a forgettable month for the stock market, but it turned out to be the opposite for Apple stock (NASDAQ:AAPL). The tech giant wrapped up its hotly anticipated Far Out event recently, where it unveiled the latest versions of the iPhone, AirPods, and Apple Watch, much to the delight of its loyal customer base. Moreover, despite the headwinds, its steady revenue expansion and EBITDA growth over the past year make it a solid bet over the long term. Henc

$Apple(AAPL)$apple’s blockbuster far out show has the world buzzing over what could potentially be the most successful iteration of the iphone. moreover, with its relatively strong results in the third quarter, it has the potential to continue expanding its top and bottom-line results.september has been a forgettable month for the stock market, but it turned out to be the opposite for apple stock (nasdaq:aapl). the tech giant wrapped up its hotly anticipated far out event recently, where it unveiled the latest versions of the iphone, airpods, and apple watch, much to the delight of its loyal customer base. moreover, despite the headwinds, its steady revenue expansion and ebitda growth over the past year make it a solid bet over the long term. henc

$Apple(AAPL)$This is a technical analysis article. Apple has just dropped to the next support level and is having a technical bounce from oversold.We will look at the fundamental metrics because our SID computer system uses both technicals and fundamentals to rate Apple as a Hold.In this latest drop, Apple started underperforming the Index, hurting portfolio performance and most portfolios own this stock.The big advantage of Apple is that price does as well or better than the Index. This may be changing for the short term.Portfolio managers avoid underperforming stocks, so this negative change in Apple needs to be reversed as it has in the the 

$iSpecimen Inc.(ISPC)$), a global online marketplace that connects scientists in need of biospecimens for medical research with healthcare organizations that can provide them, announced today that the Company gave three presentations at this year’s International Society for Biological and Environmental Repositories (ISBER) Annual Meeting in Atlanta, Ga.Jill Mullan, iSpecimen’s Chief Operating Officer, gave an oral presentation on an accepted abstract titled, “Biospecimen Matchmaking: The Data-Driven Journey from Internal Spreadsheets to Online Inventories to Just-in-Time Biobanking.” The presentation focused on how, after two decades, biobanks are now at a crossroads, as precision medicine requires more customized biospecimen collections with comp